Skip to main content

Breast Cancer During Pregnancy: Medical Therapy and Prognosis

  • Chapter
Cancer and Pregnancy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 178))

Abstract

The pathological features of breast cancer diagnosed during pregnancy have been analyzed in numerous studies. Because of the retrospective nature of such studies and the paucity of casecontrol studies it is impossible to directly compare the biological properties of breast cancer in pregnant and nonpregnant patients of similar age. The vast majority of breast cancers are invasive ductal (Woo et al. 2003). It is likely that, in addition to larger tumor diameters and more frequent involvement of the regional lymph nodes, breast cancers in pregnancy are characterized by poor differentiation and low expression of estrogen and progesterone receptors (Fig. 5.1) (Bonnier et al. 1997; Gentilini et al. 2004; Middleton et al. 2003; Miller et al. 2005; Reed et al. 2003; Ring et al. 2005); a recent review identified 13 studies reporting estrogen receptors in breast cancers diagnosed during pregnancy; estrogen receptors were negative in 138 of 235 patients (59%, 95% confidence interval 52%–65%) (Woo et al. 2003). The proportion of breast cancers with overexpression of HER-2 protein was similar in pregnant and in young nonpregnant patients (Aziz et al. 2003; Colleoni et al. 2002; Middleton et al. 2003).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson BO, Petrek JA, Byrd DR et al. (1996) Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 3: 204–211

    Article  PubMed  CAS  Google Scholar 

  2. Aviles A and Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2: 173–177

    PubMed  CAS  Google Scholar 

  3. Aziz S, Pervez S, Khan S et al. (2003) Case control study of novel prognostic markers and disease outcome in pregnancy/lactation-associated breast carcinoma. Pathol Res Pract 199: 15–21

    Article  PubMed  Google Scholar 

  4. Barthelmes L and Gateley CA (2004) Tamoxifen and pregnancy. Breast 13: 446–451

    Article  PubMed  CAS  Google Scholar 

  5. Barthelmes L, Davidson LA, Gaffney C et al. (2005) Pregnancy and breast cancer. BMJ 330: 1375–1378

    Article  PubMed  Google Scholar 

  6. Bonnier P, Romain S, Dilhuydy JM et al. (1997) Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 72: 720–727

    Article  PubMed  CAS  Google Scholar 

  7. Bradley B, Fleck A, Osei EK (2006) Normalized data for the estimation of fetal radiation dose from radiotherapy of the breast. Br J Radiol 79: 818–827

    Article  PubMed  CAS  Google Scholar 

  8. Cancer Care Ontario (2006) Breast Cancer Evidence-based Series and Practice Guidelines, Vol. 2006, Cancer Care Ontario

    Google Scholar 

  9. Cardonick E and Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5: 283–291

    Article  PubMed  CAS  Google Scholar 

  10. Carlson RW, Anderson BO, Burstein HJ et al. (2006) NCCN Clinical Practice Guidelines in Oncology. Breast Cancer

    Google Scholar 

  11. Chang YT, Loong CC, Wang HC et al. (1994) Breast cancer and pregnancy. Zhonghua Yi Xue Za Zhi (Taipei) 54: 223–229

    CAS  Google Scholar 

  12. Colleoni M, Bonetti M, Coates AS et al. (2000) Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol 18: 584–590

    PubMed  CAS  Google Scholar 

  13. Colleoni M, Rotmensz N, Robertson C et al. (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13: 273–279

    Article  PubMed  CAS  Google Scholar 

  14. Culbert EC and Schfirin BS (2006) Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions. Obstet Gynecol 108: 789–791

    PubMed  Google Scholar 

  15. Cullins SL, Pridjian G, Sutherland CM (1994) Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation. JAMA 271: 1905–1906

    Article  PubMed  CAS  Google Scholar 

  16. Cunha GR, Taguchi O, Namikawa R et al. (1987) Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum Pathol 18: 1132–1143

    PubMed  CAS  Google Scholar 

  17. Cuvier C, Espie M, Extra JM et al. (1997) Vinorelbine in pregnancy. Eur J Cancer 33: 168–169

    Article  PubMed  CAS  Google Scholar 

  18. De Santis M, Lucchese A, De Carolis S et al. (2000) Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care (Engl) 9: 235–237

    Article  Google Scholar 

  19. Diel IJ, Solomayer EF, Costa SD et al. (1998) Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 339: 357–363

    Article  PubMed  CAS  Google Scholar 

  20. Einarson A, Maltepe C, Navioz Y et al. (2004) The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 111: 940–943

    Article  PubMed  CAS  Google Scholar 

  21. Fanale MA, Uyei AR, Theriault RL et al. (2005) Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 6: 354–356

    PubMed  CAS  Google Scholar 

  22. Gadducci A, Cosio S, Fanucchi A et al. (2003) Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 23: 5225–5229

    PubMed  Google Scholar 

  23. Gentilini O, Cremonesi M, Trifiro G et al. (2004) Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15: 1348–1351

    Article  PubMed  CAS  Google Scholar 

  24. Giacalone PL, Laffargue F, Benos P (1999) Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer 86: 2266–2272

    Article  PubMed  CAS  Google Scholar 

  25. Goldhirsch A, Glick JH, Gelber RD et al. (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16: 1569–1583

    Article  PubMed  CAS  Google Scholar 

  26. Guinee VF, Olsson H, Moller T et al. (1994) Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343: 1587–1589

    Article  PubMed  CAS  Google Scholar 

  27. Hahn KM, Johnson PH, Gordon N et al. (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107: 1219–1226

    Article  PubMed  Google Scholar 

  28. Hebert-Croteau N, Freeman CR, Latreille J et al. (2004) A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat 88: 187–196

    Article  PubMed  Google Scholar 

  29. Henderson IC, Berry DA, Demetri GD et al. (2003) Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21: 976–983

    Article  PubMed  CAS  Google Scholar 

  30. Hershman DL, Wang X, McBride R et al. (2006) Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65: 1353–1360

    Article  PubMed  Google Scholar 

  31. Ibrahim EM, Ezzat AA, Baloush A et al. (2000) Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol 17: 293–300

    PubMed  CAS  Google Scholar 

  32. Illidge TM, Hussey M, Godden CW (1996) Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol (R Coll Radiol) 8: 257–258

    CAS  Google Scholar 

  33. Isaacs RJ, Hunter W, Clark K (2001) Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review. Gynecol Oncol 80: 405–408

    Article  PubMed  CAS  Google Scholar 

  34. Ishida T, Yokoe T, Kasumi F et al. (1992) Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 83: 1143–1149

    PubMed  CAS  Google Scholar 

  35. Kal HB and Struikmans H (2005) Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 6: 328–333

    Article  PubMed  Google Scholar 

  36. Kaufmann M, Hortobagyi GN, Goldhirsch A et al. (2006) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 24: 1940–1949

    Article  PubMed  Google Scholar 

  37. Kelly H, Graham M, Humes E et al. (2006) Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer 7: 339–341

    PubMed  Google Scholar 

  38. Kremer LC, van Dalen EC, Offringa M et al. (2001) Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 19: 191–196

    PubMed  CAS  Google Scholar 

  39. Kremer LC, van der Pal HJ, Offringa M et al. (2002a) Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13: 819–829

    Article  PubMed  CAS  Google Scholar 

  40. Kremer LCM, van Dalen EC, Offringa M et al. (2002b) Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol 13: 503–512.

    Article  PubMed  CAS  Google Scholar 

  41. Loibl S, von Minckwitz G, Gwyn K et al. (2006). Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106: 237–246

    Article  PubMed  Google Scholar 

  42. Mamounas EP, Bryant J, Lembersky B et al. (2005) Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J Clin Oncol 23: 3686–3696

    Article  PubMed  CAS  Google Scholar 

  43. Martin M, Pienkowski T, Mackey J et al. (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352: 2302–2313

    Article  PubMed  CAS  Google Scholar 

  44. Mazonakis M, Varveris H, Damilakis J et al. (2003) Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 55: 386–391

    Article  PubMed  Google Scholar 

  45. Meyer-Wittkopf M, Barth H, Emons G et al. (2001) Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 18: 62–66

    Article  PubMed  CAS  Google Scholar 

  46. Middleton LP, Amin M, Gwyn K et al. (2003) Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 98: 1055–1060

    Article  PubMed  Google Scholar 

  47. Miller KD, Chap LI, Holmes FA et al. (2005) Randomized Phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 23: 792–799

    Article  PubMed  CAS  Google Scholar 

  48. Nieto Y, Santisteban M, Aramendia JM et al. (2006) Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer 6: 533–534

    Article  PubMed  Google Scholar 

  49. Nugent P and O’Connell TX (1985) Breast cancer and pregnancy. Arch Surg 120: 1221–1224

    PubMed  CAS  Google Scholar 

  50. Oksuzoglu B and Guler N (2002) An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol 104: 79

    Article  PubMed  Google Scholar 

  51. Oktay K, Buyuk E, Libertella N et al. (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23: 4347–4353

    Article  PubMed  CAS  Google Scholar 

  52. Pavlakis N, Schmidt R, Stockler M (2005) Bisphosphonates for breast cancer. Cochrane Database Syst Rev: CD003474

    Google Scholar 

  53. Petrek JA, Dukoff R, Rogatko A (1991) Prognosis of pregnancy-associated breast cancer. Cancer 67: 869–872

    Article  PubMed  CAS  Google Scholar 

  54. Piccart-Gebhart MJ, Procter M, Leyland-Jones B et al. (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353: 1659–1672

    Article  PubMed  CAS  Google Scholar 

  55. Potluri V, Lewis D, Burton GV (2006) Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer 7: 167–170

    PubMed  Google Scholar 

  56. Powles T, Paterson A, McCloskey E et al. (2006) Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res 8: R13

    Article  PubMed  CAS  Google Scholar 

  57. Reed W, Hannisdal E, Skovlund E et al. (2003). Pregnancy and breast cancer: a population-based study. Virchows Arch 443: 44–50

    Article  PubMed  CAS  Google Scholar 

  58. Ring AE, Smith IE, Jones A et al. (2005) Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 23: 4192–4197

    Article  PubMed  Google Scholar 

  59. Roché H, Fumoleau P, Spielmann M et al. (2004) Five-year analysis of the PACS 01 trial: 6 cycles of FEC100 cs. 3 cycles of FEC100 followed by 3 cycles of docetaxel (D) for the adjuvant treatment of node positive breast cancer. Breast Cancer Res Treat 88 Suppl 1: S16

    Google Scholar 

  60. Romond EH, Perez EA, Bryant J et al. (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353: 1673–1684

    Article  PubMed  CAS  Google Scholar 

  61. Say L, Kulier R, Gulmezoglu M et al. (2005) Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database Syst Rev: CD003037

    Google Scholar 

  62. Slamon D, Eiermann W, Robert N et al. (2005) Phase III trial comparing AC-T with AC-TH and with TCH in the adjuvant treatment of HER2 positive early breast cancer patients: first interim efficacy analysis. Breast Cancer Res Treat 89, Suppl. 1: S5 (Abstract #1)

    Google Scholar 

  63. Smith IE, Dowsett M, Yap YS et al. (2006) Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines. J Clin Oncol 24: 2444–2447

    Article  PubMed  CAS  Google Scholar 

  64. Tewari K, Bonebrake RG, Asrat T et al. (1997) Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet 350 :183

    Google Scholar 

  65. Vujovic O, Yu E, Cherian A et al. (2006) Eleven-year follow-up results in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients. Int J Radiat Oncol Biol Phys 64: 760–764

    Article  PubMed  Google Scholar 

  66. Waterston AM and Graham J (2006) Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol 24: 321–322.

    Article  PubMed  Google Scholar 

  67. Watson WJ (2005) Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol 105: 642–643

    PubMed  Google Scholar 

  68. Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138: 91–98; discussion 99

    Article  PubMed  Google Scholar 

  69. Zemlickis D, Lishner M, Degendorfer P et al. (1996) Maternal and fetal outcome following breast cancer in pregnancy. In Cancer in pregnancy. Maternal and fetal risks., Koren, G., Lishner, M. & Farine, D. (eds) pp. 95–115. Cambridge University Press: New York

    Google Scholar 

  70. Zemlickis D, Lishner M, Degendorfer P et al. (1992) Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166: 781–787

    PubMed  CAS  Google Scholar 

  71. Zhang J, Liu G, Wu J et al. (2003) Pregnancy-associated breast cancer: a case control and long-term follow-up study in China. J Exp Clin Cancer Res 22: 23–27

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Aebi, S., Loibl, S. (2008). Breast Cancer During Pregnancy: Medical Therapy and Prognosis. In: Cancer and Pregnancy. Recent Results in Cancer Research, vol 178. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71274-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-71274-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-71272-5

  • Online ISBN: 978-3-540-71274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics